Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors?

Procept BioRobotics CEO Larry Wood purchased 23,900 shares (~$498,000) through a trust on August 7, 2026, expanding his beneficial stake to 338,103 shares. The purchase occurred as the stock declined 48% over the past year, but comes after the company reported 19% Q2 sales growth and Wood's reorganization efforts. Insider purchases are typically viewed as bullish signals, suggesting management confidence in the company's turnaround prospects despite ongoing net losses of $109.8 million on $337.3 million in trailing revenue.